|
About:
|
Technology involving pulmonary arterial high blood pressure patient-specific activated pluripotent stem cell collections coming from 3 irrelevant individuals which has a heterozygous missense mutation throughout exon 14, the heterozygous in-frame deletion throughout exon Several as well as a missense mutation inside exon 12 of the BMPR2 gene.
|